Jerome Rossert
Company: AstraZeneca
Job title: Vice President, Head of Clinical Renal
Seminars:
Chair’s Closing Remarks 5:00 pm
day: Day One
One-Size Does Not Fit All: Implementing Precision Medicine Approaches to Targeted Therapeutics 10:45 am
day: Track 2 - Day 1 AM
Panel Discussion: How can we Modernize Surrogate Endpoint Development? Moving Beyond Hard Endpoints 8:00 am
Evaluating novel surrogate endpoints in addition to emerging standard of care Non-invasive imaging, patient-reported outcomes, UACR, and more: what is an acceptable endpoint? Considering payers perspectives’ on moving beyond hard endpoints and ESRDRead more
day: Day One
Chair’s Opening Remarks 7:55 am
day: Day One